The Wall Street Journal: New gene therapy priced at $1.8 million in Europe

A new gene therapy for a rare blood disorder will sell for €1.6 million ($1.8 million) in Europe, according to the maker of the recently approved treatment, whose sticker price is the latest indication that already high drug costs are continuing to climb.